12^th UK Academic Screening Groups Meeting

Jury’s Inn, 31 Keel Wharf, Liverpool L3 4FN

Wednesday 9^th September 2009

 

Agenda

Morning Session (Open)

Drug Discovery within UK Academic Institutes

Chair Person: Wynne Aherne (ICR)

Co-Chairs: Debbie Taylor (MRCT CTD), Tim Hammonds (CRT)

9.00 – 9.10am Introduction – Wynne Aherne

9.10 – 9.35am Mechanism-Based Cancer Drug Discovery: Strategies for Hit Generation

Wynne Aherne, Institute for Cancer Research, Centre for Cancer Therapeutics

9.35 – 9.55am Antibody Translation: from Mouse to Human Therapeutic

David G. Williams, MRC Technology Centre for Therapeutics Discovery

9.55 – 10.20am Biochemical HTS: What to do with a 10% hit rate from a non-focus compound library

Fabrice Tulais, Cancer Research Technology

10.20 – 10.45am Coffee Break

10.45 – 11.10am Developing High Quality Quantitative Assays for Intracellular

Parasites

Manu De Rycker, University of Dundee

11.10 – 11.35am A High-Throughput Screening Facility for the Cancer Research UK London Research Institute

Michael Howell – Cancer Research UK

11.35 – 12.00 Noon UK Drug Discovery Consortium

Julie Frearson, Chairperson UKDDC

12.00 – 12.30pm Technologies and Strategies That Drive Productivity and Biological Relevance in Discovery

Tom Livelli, Invitrogen

12.30pm Lunch

Closed Meeting Follows